Biomacromolecules · 2015 · 53 citations · 45 references
Life SciencesImmunologyNeuroscienceImmunotherapyInflammationNeuroimmunologyDemyelinating DiseasesDemyelinating DisordersDendritic Cell BiologyMultiple SclerosisNeuroinflammationNeuroprotectionExperimental Autoimmune EncephalomyelitisFingolimod TherapyImmune-mediated DemyelinationMultiple Sclerosis ModelsMultiple Sclerosis TherapyMyelin AntigensNeuroinflammation In Multiple SclerosisT Cell Response Induction
Dendrimers are polyfunctional nano-objects of perfectly defined structure that can provide innovative alternatives for the treatment of chronic inflammatory diseases, including multiple sclerosis (MS). To investigate the efficiency of a recently described amino-bis(methylene phosphonate)-capped ABP dendrimer as a potential drug candidate for MS, we used the classical mouse model of MOG35-55-induced experimental autoimmune encephalomyelitis (EAE). Our study provides evidence that the ABP dendrimer prevents the development of EAE and inhibits the progression of established disease with a comparable therapeutic benefit as the approved treatment Fingolimod. We also show that the ABP dendrimer redirects the pathogenic myelin-specific CD4(+) T cell response toward IL-10 production.
45
Peter A. Calabresi, Ernst-Wilhelm Radüe, Douglas S. Goodin et al. · The Lancet Neurology · 2014 · 822 citations
Itzhack Mendel, Nicole Kerlero de Rosbo, Avraham Ben‐Nun · European Journal of Immunology · 1995 · 604 citations
Type II monocytes modulate T cell–mediated central nervous system autoimmune disease
Martin S. Weber, Thomas Prod’homme, Sawsan Youssef et al. · Nature Medicine · 2007 · 448 citations